Literature DB >> 18713696

Irreversible electroporation attenuates neointimal formation after angioplasty.

Elad Maor1, Antoni Ivorra, Jonathan Leor, Boris Rubinsky.   

Abstract

UNLABELLED: Restenosis following coronary angioplasty represents a major clinical problem. Irreversible electroporation (IRE) is a nonthermal, nonpharmacological cell ablation method. IRE utilizes a sequence of electrical pulses that produce permanent damage to tissue within a few seconds. METHODS AND
RESULTS: The left carotid arteries of eight rats underwent in vivo intimal damage using two Fogarty angioplasty catheters. The procedure was immediately followed by IRE ablation in four rats, while the remaining four were used as the control group. The IRE ablation was performed using a sequence of ten dc pulses of 3800 V/cm, 100 micros each, at a frequency of ten pulses per second, applied across the blood vessel between two parallel electrodes. The electrical conductance of the treated tissue was measured during the electroporation to provide real-time feedback of the process. Left carotid arteries were excised and fixated after a 28-day follow-up period. Neointimal formation was evaluated histologically. The use of IRE was successful in three out of four animals in a way that is consistent with the measurements of blood vessel electrical properties. The integrity of the endothelial layer was recovered in the IRE-treated animals, compared with control. Successful IRE reduced neointima to media ratio (0.57 +/-0.4 versus 1.88 +/-1.0, P = 0.02).
CONCLUSIONS: We report for the first time the in vivo results of attenuation of neointimal formation using IRE. Our study shows that IRE might be able to attenuate neointimal formation after angioplasty damage in a rodent model of restenosis. This approach may open new venues in the treatment of coronary artery restenosis after balloon angioplasty.

Entities:  

Mesh:

Year:  2008        PMID: 18713696     DOI: 10.1109/TBME.2008.923909

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  10 in total

Review 1.  Microscale electroporation: challenges and perspectives for clinical applications.

Authors:  Won Gu Lee; Utkan Demirci; Ali Khademhosseini
Journal:  Integr Biol (Camb)       Date:  2009-01-29       Impact factor: 2.192

2.  Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation.

Authors:  Elad Maor; Antoni Ivorra; James J Mitchell; Boris Rubinsky
Journal:  J Vasc Interv Radiol       Date:  2010-10-08       Impact factor: 3.464

3.  A statistical model for multidimensional irreversible electroporation cell death in tissue.

Authors:  Alex Golberg; Boris Rubinsky
Journal:  Biomed Eng Online       Date:  2010-02-26       Impact factor: 2.819

Review 4.  Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review.

Authors:  Salvatore Paiella; Roberto Salvia; Marco Ramera; Roberto Girelli; Isabella Frigerio; Alessandro Giardino; Valentina Allegrini; Claudio Bassi
Journal:  Gastroenterol Res Pract       Date:  2016-02-15       Impact factor: 2.260

Review 5.  Time-Dependent Impact of Irreversible Electroporation on Pancreas, Liver, Blood Vessels and Nerves: A Systematic Review of Experimental Studies.

Authors:  J A Vogel; E van Veldhuisen; P Agnass; J Crezee; F Dijk; J Verheij; T M van Gulik; M R Meijerink; L G Vroomen; K P van Lienden; M G Besselink
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

Review 6.  Innovations in Clinical Cardiac Electrophysiology: Challenges and Upcoming Solutions in 2018 and Beyond.

Authors:  Vaibhav R Vaidya; Alan Sugure; Samuel J Asirvatham
Journal:  J Innov Card Rhythm Manag       Date:  2017-12-15

7.  Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation.

Authors:  Elad Maor; Antoni Ivorra; Boris Rubinsky
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

Review 8.  Percutaneous ablation of pancreatic cancer.

Authors:  Mirko D'Onofrio; Valentina Ciaravino; Riccardo De Robertis; Emilio Barbi; Roberto Salvia; Roberto Girelli; Salvatore Paiella; Camilla Gasparini; Nicolò Cardobi; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

9.  Antitumor Efficacy of Liposome-Encapsulated NVP-BEZ235 Combined with Irreversible Electroporation for Head and Neck Cancer.

Authors:  Li Tian; Lucas Wang; Yang Qiao; Linfeng Lu; Patrick Lee; Ashley Chang; Saisree Ravi; Thomas A Rogers; Marites P Melancon
Journal:  Molecules       Date:  2019-10-01       Impact factor: 4.411

10.  Feasibility of selective cardiac ventricular electroporation.

Authors:  Alan Sugrue; Vaibhav R Vaidya; Christopher Livia; Deepak Padmanabhan; Anas Abudan; Ameesh Isath; Tyra Witt; Christopher V DeSimone; Paul Stalboerger; Suraj Kapa; Samuel J Asirvatham; Christopher J McLeod
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.